Royal Bank Of Canada Tarsus Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 6,683 shares of TARS stock, worth $311,761. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,683

Previous 6,245 7.01%

Holding current value

$311,761

Previous $169,000 29.59%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$21.54 - $34.6 $9,434 - $15,154	438 Added 7.01%	6,683 $219,000
Q2 2024 Aug 14, 2024	BUY	$25.17 - $38.73 $74,880 - $115,221	2,975 Added 90.98%	6,245 $169,000
Q1 2024 Nov 05, 2024	SELL	$19.61 - $39.22 $58,339 - $116,679	-2,975 Reduced 47.64%	3,270 $118,000
Q1 2024 May 15, 2024	SELL	$19.61 - $39.22 $195,001 - $390,003	-9,944 Reduced 75.25%	3,270 $118,000
Q4 2023 Feb 14, 2024	BUY	$12.98 - $20.73 $89,964 - $143,679	6,931 Added 110.31%	13,214 $267,000
Q3 2023 Nov 14, 2023	BUY	$14.75 - $24.62 $51,123 - $85,332	3,466 Added 123.04%	6,283 $111,000
Q2 2023 Aug 14, 2023	BUY	$11.57 - $19.63 $17,910 - $30,387	1,548 Added 121.99%	2,817 $50,000
Q1 2023 May 15, 2023	SELL	$11.92 - $16.27 $20,073 - $27,398	-1,684 Reduced 57.03%	1,269 $15,000
Q4 2022 Feb 14, 2023	BUY	$14.12 - $18.72 $35,441 - $46,987	2,510 Added 566.59%	2,953 $43,000
Q3 2022 Nov 14, 2022	BUY	$14.08 - $18.5 $1,703 - $2,238	121 Added 37.58%	443 $8,000
Q2 2022 Aug 15, 2022	SELL	$11.08 - $19.08 $4,598 - $7,918	-415 Reduced 56.31%	322 $4,000
Q1 2022 May 16, 2022	SELL	$14.49 - $24.28 $20,430 - $34,234	-1,410 Reduced 65.67%	737 $13,000
Q4 2021 Feb 14, 2022	BUY	$21.21 - $29.68 $25,918 - $36,268	1,222 Added 132.11%	2,147 $49,000
Q3 2021 Nov 15, 2021	BUY	$21.45 - $29.22 $7,464 - $10,168	348 Added 60.31%	925 $20,000
Q2 2021 Aug 16, 2021	BUY	$27.16 - $38.59 $15,671 - $22,266	577 New	577 $17,000

Others Institutions Holding TARS

# of Institutions

170

Shares Held

43.3M

Call Options Held

484K

Put Options Held

4.1K

View Full List

About Tarsus Pharmaceuticals, Inc.

Ticker TARS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,658,500
Market Cap $1.24B
Description
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...

More about TARS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Tarsus Pharmaceuticals, Inc. Transaction History